ClinicalTrials.gg
Not yet recruitingNCT07870343Updated Oct 13, 2026

Healthcare and Community Service Utilisation in Older Survivors of Critical Illness

An observational study in Critical Illness, sponsored by Monash University. Not yet recruiting at 1 site in Australia. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Monash University · Observational

Updated Oct 13, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
65 Years and older
Sex
All
01

Study summary

This prospective observational study will describe healthcare and community service utilisation among older adults who survive critical illness and return to the community following hospital discharge. Participants will be adults aged 65 years or older who have been admitted to an intensive care unit (ICU) for at least 48 hours and survive to hospital discharge. Healthcare and community service use will be assessed during the first 90 days after hospital discharge using weekly telephone surveys, participant-completed health diaries, and review of participants' electronic medical records. The study will describe use of general practitioner, medical specialist, allied health, nursing and community services, as well as self-reported needs and barriers to accessing these services, emergency department presentations, hospital readmissions and mortality. Findings will help inform the development of future models of follow-up care for older survivors of critical illness.

02

Conditions studied

  • Critical Illness

Browse trials for

03

In context

Critical Illness

1,924 studies on the registry are indexed under Critical Illness; 465 are open to participants now.

This study's planned enrollment of 30 is below the median of 130 across 883 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Monash University is the lead sponsor of 83 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People aged ≥65 years who are admitted to ICU for at least 48 hours and survive until hospital discharge.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Was admitted to ICU for ≥48 hours
  2. Is aged ≥65 years old
  3. Is returning to community-dwelling

Exclusion criteria

Exclusion Criteria:

  1. Is planned for discharge against medical advice
  2. Is planned for discharge to another inpatient facility
  3. Is not expected to reside in Australia for 90 days following hospital discharge
  4. Is not expected to survive for 90 days following hospital discharge
  5. Is not able to participate in the study procedures
  6. Is not able to read and speak English
  7. Is not eligible for Medicare
  8. Has declined or is unable to provide consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Older survivors of critical illness

    Participants will be adults aged 65 years or older who have been admitted to an intensive care unit (ICU) for at least 48 hours, survive to hospital discharge, and are returning to community living. No intervention will be provided.

06

What researchers measure

Primary outcomes

  1. Utilisation of General Practitioner (GP) services

    Time frame: 90 days following hospital discharge

Secondary outcomes

  1. Utilisation of medical specialist, allied health, nursing and non-healthcare services

    Time frame: 90 days following hospital discharge

  2. Self-reported need for and barriers to accessing healthcare and community services

    Time frame: 90 days following hospital discharge

  3. All-cause mortality

    Time frame: 90 days following hospital discharge

  4. Emergency Department (ED) presentations

    Time frame: 90 days following hospital discharge

  5. Acute hospital readmissions

    Time frame: 90 days following hospital discharge

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

Of 473 non-industry observational studies under Critical Illness, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 5 months is below that.

Counting every sponsor, half of 477 studies reached it within 22 months; a quarter within 11 and three quarters within 43.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 13, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
Apr 1, 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07870343
Lead sponsor
Monash University
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Apr 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Prof Carol Hodgson
Contact
carol.hodgson@monash.edu
+61 3 9903 0598
Katherine Cox
Contact
katherine.esposito@monash.edu
Prof Carol Hodgson
principal investigator · Monash University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion